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ABSTRACT: Local drug delivery directly to the source of a
given pathology using retrodialysis is a promising approach to
treating otherwise untreatable diseases. As the primary material
component in retrodialysis, the semipermeable membrane
represents a critical point for innovation. This work presents a
new ionic hydrogel based on polyethylene glycol and acrylate
with dopamine counterions. The ionic hydrogel membrane is
shown to be a promising material for controlled diﬀusive
delivery of dopamine. The ionic nature of the membrane
accelerates uptake of cationic species compared to a nonionic
membrane of otherwise similar composition. It is demon-
strated that the increased uptake of cations can be exploited to
confer an accelerated transport of cationic species between
reservoirs as is desired in retrodialysis applications. This eﬀect
is shown to enable nearly 10-fold increases in drug delivery rates from low concentration solutions. The processability of the
membrane is found to allow for integration with microfabricated devices which will in turn accelerate adaptation into both
existing and emerging device modalities. It is anticipated that a similar materials design approach may be broadly applied to a
variety of cationic and anionic compounds for drug delivery applications ranging from neurological disorders to cancer.
Local drug delivery directly to the source of a givenpathology using implantable materials and devices is a
promising approach to treating otherwise untreatable diseases.
This approach is particularly attractive for pathologies where
systemic drug treatments have been ineﬀective due to an
inability to reach the target and/or serious side eﬀects from oﬀ
target drug interactions. Concentration-driven diﬀusion via
retrodialysis (also known as reverse microdialysis) is among
the most widely reported local drug delivery techniques to date
with numerous applications in both research and the clinic.1,2
Retrodialysis involves the delivery of compounds across a
semipermeable membrane typically using a microdialysis probe
loaded with a perfusate solution of drugs. The technique is
simple to apply and oﬀers the beneﬁt of continuous drug
delivery with minimal local pressure increase.
As the primary material component in retrodialysis, the
semipermeable membrane represents a critical point for
innovation. New membrane materials could expand applica-
tions to allow for eﬃcient delivery of low-concentration drug
solutions and to accelerate delivery of drugs with poor stability.
Likewise, new membrane materials that are compatible with
microfabrication techniques could allow for adaptation of
recently reported material/device architectures that mitigate
the foreign body response. This is particularly important as the
foreign body response is well-known to limit the long-term
eﬃcacy of medical implants for drug delivery and sensing.3−6
Previous work on microdialysis membranes has suggested
that incorporation of ﬁxed ionic groups within the membrane
can aﬀect the diﬀusion rate of charged compounds.7 We aimed
to explore if this eﬀect could also be leveraged for retrodialysis
membranes. To that end, we report here on a hydrogel based
on polyethylene glycol diacrylate (PEGDA) and a new ionic
monomer, dopamine acrylate (iDAA). The iDAA monomer
was formulated with dopamine (+) as the counterion to each
acrylate (−) ﬁxed ionic group. This also ensured optimal
permeability for controlled amounts of dopamine within the
membrane.
Dopamine is a neurotransmitter known to play an important
role in controlling movement and emotions.8,9 The death of
dopamine-producing cells has long been implicated in
Parkinson’s disease, and thus local delivery of dopamine and
dopamine-like compounds has been the subject of much
research.10−13 PEGDA based materials have been used
extensively for biological applications14−16 and can be
photopatterned in a manner compatible with standard
microfabrication procedures.17,18 Hydrated PEGDA based
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membranes are also known to have tunable swelling ratios and
to be semipermeable allowing a variety of compounds to
diﬀuse through.14,19 The combination of biocompatibility,
processability, and permeability makes PEGDA a suitable
candidate for retrodialysis applications.
As shown in Scheme 1, the iDAA monomer was prepared
exchanging the Cl− in dopamine hydrochloride with acrylate
(−) using an anion exchange resin (Alfa Aesar, Amberlyst A-
26), see Methods for detailed synthetic procedures and NMR.
iDAA was then mixed with deionized water (up to 1 M), equal
volumes of PEGDA (Mn 575, Sigma-Aldrich) and 2 wt % 2-
hydroxy-2-methylpropiophenone, and a biocompatible photo-
initiator (Darocur 1173, Sigma Aldric). The mixed solution
was deposited as desired and exposed to ultraviolet (UV) light
(100 μJ/cm2, AnalytikJena UVP Cross-linker) for 30 min to
form a fully cross-linked PEGDA-iDAA membrane (see
Scheme 1B). The composition of the PEGDA-iDAA
membranes was conﬁrmed with FTIR (Figure S1). Mem-
branes were also prepared with methyl acrylate (MA) in place
of iDAA to provide a comparison to a noncharged membrane.
Following UV exposure, membranes were soaked in phosphate
buﬀered saline (PBS 0.01M) for at least 4 h, replacing with
fresh PBS solution on an hourly basis. The membranes were
observed to be stable in PBS with no visible degradation up to
six months. Likewise, membranes were found to exhibit only
modest swelling in PBS solution with an increase in weight
content of no more than 11%. The observed stability and
minimal swelling suggest a highly cross-linked membrane. The
limited swelling is particularly important for integration with
microfabricated devices as excessive swelling can otherwise
stress nonswelling materials leading to cracking and issues with
adhesion.
As an initial test of compatibility with microfabricated
devices, PEGDA-iDAA membranes were directly patterned
onto the end of a 220 μm wide neural probe with an integrated
microﬂuidic channel20 (Figure 1). The patterning of the
membrane, 200 μm across, was made possible by selected UV
exposure of the deposited membrane solution using standard
photolithography techniques (SUSS MicroTec MJB4). Adhe-
sion to the parylene surface of the neural probe was aided by
pretreatment with methacryloxypropyl trimethoxysilane (Si-
lane A 174, Sigma-Aldrich) following previously reported
procedures.21 As with the free-standing membranes, the
PEGDA-iDAA membranes on the microﬂuidic probes
exhibited excellent stability with no signs of degradation in
PBS, suggesting that the material is well suited for retrodialysis
applications.
Following the processability testing, the diﬀusion/uptake of
molecules in the PEGDA-iDAA membrane was explored by
soaking the membranes in aqueous solutions with charged dye
molecules. In particular, to understand the eﬀect of ﬁxed
anionic groups in the membrane, three membrane composi-
tions with varying ﬁxed anion concentrations were compared:
PEGDA-MA with 500 mM concentration of MA, PEGDA-
iDAA-MA with 50 mM concentration of iDAA and 450 mM
concetnration of MA, and PEGDA-iDAA with 500 mM
concentration of iDAA. Each membrane was soaked in 1 mM
and 10 mM phenol red solutions (pH 10). After 1 h, the
membranes were removed from the solution, gently patted dry,
and photographed. They were then placed in a concentrated
NaCl solution (2 M) for 1 h during which time absorbed dye
was released into the NaCl solution. A ﬁxed volume of the
NaCl solution was then taken for UV−vis measurements to
gauge the relative concentration of phenol red. The same
procedure was followed using fresh membranes with
methylene blue in place of phenol red. The photographed
membranes and UV−vis results are shown in Figure 2A for
phenol red (450 nm) and Figure 2B for methylene blue (670
nm). The absorption data was normalized by volume of the
membrane to account for variations in dimensions.
Prior to soaking membranes in dye solutions, they were
observed to be transparent with only negligible absorption
across the visible spectrum. After soaking in phenol red, the
membranes took a yellow hue that increased with increasing
concentration, suggesting some uptake of the anionic dye. The
absorbed concentration of phenol red was found to be greatest
in the uncharged PEGDA-MA membrane with decreasing
uptake as the concentration of iDAA increased. This can be
understood by considering that the ﬁxed acrylate(−) groups in
the PEGDA-iDAA membrane act as an electrostatic barrier to
the diﬀusion/uptake of anionic compounds as is typical for
polyanions.22 In contrast, the opposite trend was observed
when membranes were soaked in the cationic methylene blue
solution with increasing uptake of methylene blue as the iDAA
content increased. In fact, the normalized absorption from
methylene blue was more than 10-fold higher for the PEGDA-
iDAA membrane compared to the PEGDA-MA membrane.
We posit this phenomenon can be explained by considering
that the ﬁxed acrylate(−) groups are each compensated by a
Scheme 1. (A) Formation of iDAA by Exchange of Cl(−)
with Acrylate(−) and B) Combination of PEGDA, iDAA,
and H2O with a Photoiniator and UV Light To Form
PEGDA-iDAA
Figure 1. Image of PEGDA-iDAA membrane patterned at the end of
the neural probe with an integrated microﬂuidic channel. Scale bar
200 μm.
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counterion in the form of a freely moving cation. Initially the
counterions are primarily Na+, and upon introduction of
methylene blue(+) some portion of the counterions are
exchanged. The higher concentration of ﬁxed ions and
counterions in the membrane compared to concentration of
the dye solution drives a higher uptake of the cationic
methylene blue within the membrane than would be expected
in the absence of ﬁxed charge. Together these results indicate
the charged PEGDA-iDAA membrane is well suited to
preferentially transport cationic species.
Having observed the ability to preferentially uptake cationic
species at an accelerated rate, the suitability of PEGDA-iDAA
membranes for retrodialysis of dopamine was subsequently
tested in a model system. Membranes were sandwiched
between two wells with the membrane serving as a bridge
material connecting the contents of each well (see Supporting
Information). One well was designated as the Source side and
was ﬁlled with an aqueous solution of dopamine hydrochloride.
The other well served as the Target and was ﬁlled with PBS to
mimic the biological environment. After a set time period, the
solution in the Target was collected and analyzed with
diﬀerential pulse voltammetry23,24 to measure the amount of
dopamine delivered from the Source well to the Target well
(see Supporting Information). Figure 3 shows the measured
concentration of dopamine in the Target as a function of time
for a dopamine Source concentration of 12 mM using either
the PEGDA-iDAA or the PEGDA-MA membranes. The inset
illustrates the relative initial ion concentrations in the Source,
membrane, and Target. It should be noted that membranes
were repeatedly rinsed and soaked in saline solution to remove
any residual dopamine prior to starting the dopamine diﬀusion
experiments. For all time points, it was observed that there was
nearly 10-fold more dopamine transferred from the Source to
the Target with the PEGDA-iDAA membrane compared to the
PEGDA-MA. This is especially noteworthy given that the
Target contained smaller, more mobile cations (Na) at greater
than 10 times the concentration of dopamine in the Source as
such conditions are typical for drug delivery applica-
tions.20,25,26 We posit that these results can be understood
by considering that the relatively high concentration of ﬁxed
anions in the PEGDA-iDAA membrane leads to an enhanced
uptake of dopamine from the Source similar to what was
observed in the charged dye experiments. As the PEGDA-
iDAA membrane ﬁlls with a higher concentration of dopamine
compared to the uncharged PEGDA-MA membrane, this in
turn creates a higher concentration gradient for dopamine
Figure 2. (A) Normalized absorption at 450 nm for PEGDA-MA,
PEGDA-MA-iDAA, and PEGDA-iDAA membranes before and after
soaking in 1 mM and 10 mM phenol red solutions with images of the
corresponding membranes above each bar (membrane width
approximately 1 cm each). (B) Normalized absorption at 670 nm
for PEGDA-MA, PEGDA-MA-iDAA, and PEGDA-iDAA membranes
before and after soaking in 1 mM and 10 mM methylene blue
solutions with images of the corresponding membranes above each
bar (membrane width approximately 1 cm each).
Figure 3. Concentration of dopamine measured in the Target well as
a function of time using PEGDA-iDAA and PEGDA-MA membranes
with an initial dopamine concentration of 12 mM in the Source well.
The inset illustrates the relative ionic concentration in the Source,
membrane, and Target. (B) Schematic showing ion exchange at the
Source/PEGDA-iDAA interface (top) as well as the PEGDA-iDAA/
Target interface (bottom) at time zero and after some minutes. Brown
cations represent dopamine with sodium represented by red cations,
ﬁxed acrylate anion in blue, and chlorine anions in green.
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relative to the Target and thus a higher diﬀusive ﬂux. A similar
phenomenon has previously been reported for cation transport
in porous ion exchange membranes.27
This ion exchange phenomenon is illustrated in Figure 3B
wherein a simpliﬁed schematic of the ion exchanges is shown
at the Source/PEGDA-iDAA interface (top) as well as
PEGDA-iDAA/Target interface (bottom) at time zero and
after some minutes. Brown cations represent dopamine with
sodium represented by red cations, the ﬁxed acrylate anion is
in blue, and the chlorine anions are in green (the low
concentration of phosphate and potassium ions in the Target
are excluded for clarity). As illustrated, ion exchange facilitates
uptake of dopamine into the PEGDA-iDAA membrane at the
Source side and which then leads to dopamine exchange with
(primarily) sodium ions at the Target side. Note that this
means there is also a ﬂux of sodium from the Target to the
Source by the same mechanism.
The drug delivery capacity of the PEGDA membranes was
explored further using the same Source−membrane−Target
setup to measure the eﬀect of Source concentration. Figure 4
shows the concentration of dopamine measured in the Target
after 30 min for Source dopamine concentrations from 1 mM
to 1.7 M. The ﬁgure inset indicates the relative ion
concentrations on a log scale for each region. In the case
that the Source concentration was less than the ﬁxed ion
concentration in the PEGDA-iDAA membrane (approximately
500 mM), a pronounced increase in delivered dopamine was
observed relative to the PEGDA-MA membrane. However, the
diﬀerence in transported dopamine was negligible between the
two membranes for Source concentrations above the PEGDA-
iDAA ﬁxed ion concentration. This ﬁnding supports the notion
that the ﬁxed ions in the PEGDA-iDAA membrane drive the
accelerated diﬀusion observed at lower Source concentrations.
When the Source concentration signiﬁcantly exceeds the ﬁxed
ion concentration in the membrane, it follows that after some
time the concentration of dopamine in the PEGDA-iDAA
membrane would be similar to that observed in the system
with the uncharged PEGDA-MA membrane. Consequently, in
these conditions the diﬀusive ﬂux from the Source to the
Target for both membrane systems is primarily a function of
the Source concentration and is therefore similar in magnitude.
Altogether the results presented here suggest that the
PEGDA-iDAA membrane is a promising material for
controlled diﬀusive delivery of dopamine. The ionic nature
of the membrane accelerates uptake of cationic species
compared to a nonionic membrane of otherwise similar
composition. The increased uptake of cations can be exploited
to confer an accelerated transport of cationic species between
reservoirs as is desired in retrodialysis applications. This eﬀect
can enable nearly 10-fold increases in drug delivery rates from
low concentration solutions (<100 mM). Equally important,
the processability of the PEGDA-iDAA membrane readily
enables integration with microfabricated devices which can in
turn accelerate adaptation into both existing and emerging
device modalities. While the work here was focused on delivery
of dopamine, we anticipate that a similar materials design
approach may be broadly applied to a variety of cationic and
anionic compounds for drug delivery applications ranging from
neurological disorders to cancer.
■ METHODS
Synthesis of Ionic Dopamine Acrylate Monomer (iDAA).
The synthesis of iDAA was carried out using an anionic exchange
resin (AER), Amberlyst A-26 (OH) from Alfa Aesar (exchange
capacity 0.8 mol/L), an excess (>10% p/V) of commercial acrylic acid
(Sigma-Aldrich) in water, and 0.05 M dopamine chloride (Alfa Aesar)
in methanol. The AER column was loaded with an excess of acrylic
acid solution (>10% p/V). Then, a 0.05 M dopamine chloride
solution in methanol was passed slowly through the column. The ﬁnal
product, dopamine acrylate (iDAA), was collected in the form of a
methanol solution. Methanol was removed under reduced pressure,
and the iDAA was characterized by 1H NMR (400 MHz, Deuterium
Oxide) δ 6.86−6.69 (m, 3H, aromatic), 6.13−5.60 (m, 3H, CH2
CH), 3.17 (t, 2H, CH2−CH2−NH3), 2.82 (t, 2H, CH2−CH2-NH3).
Diﬀerential Pulse Voltammetry (DPV). DPV measurements
were performed using a three electrode conﬁguration with a glassy
carbon working electrode, Pt-wire counter electrode, and Ag/AgCl
reference electrode using an Metrohm Autolab Potentiostat (model
PGSTAT128N). Glass carbon electrodes were cleaned thoroughly
prior to each measurement. Unknown concentrations of dopamine
were determined using a calibration curve of measured current at the
0.14 V peak for known concentrations of dopamine.
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(1) Höcht, C.; Opezzo, J. A. W.; Taira, C. A. Applicability of Reverse
Microdialysis in Pharmacological and Toxicological Studies. J.
Pharmacol. Toxicol. Methods 2007, 55 (1), 3−15.
(2) Melgaard, L.; Hersini, K. J.; Gazerani, P.; Petersen, L. J.
Retrodialysis: A Review of Experimental and Clinical Applications of
Reverse Microdialysis in the Skin. Skin Pharmacol Physiol 2013, 26
(3), 160−174.
(3) Lecomte, A.; Descamps, E.; Bergaud, C. A Review on
Mechanical Considerations for Chronically-Implanted Neural Probes.
J. Neural Eng. 2018, 15 (3), 031001.
(4) Rivnay, J.; Wang, H.; Fenno, L.; Deisseroth, K.; Malliaras, G. G.
Next-Generation Probes, Particles, and Proteins for Neural Interfac-
ing. Science Advances 2017, 3 (6), e1601649.
(5) Veronica, A.; Li, Y.; Hsing, I-m. Minimally Invasive & Long-
Lasting Neural Probes from a Materials Perspective. Electroanalysis
2019, 31 (4), 586−602.
(6) Tan, S. A.; Aebischer, P. The Problems of Delivering
Neuroactive Molecules to the CNS. Ciba Foundation Symposium
196 - Growth Factors as Drugs for Neurological and Sensory Disorders;
Wiley: 2007; Vol. 196, pp 211−239; discussion pp 236−239.
(7) Tao, R.; Hjorth, S. Differences in the In Vitro and In Vivo 5-
Hydroxytryptamine Extraction Performance Among Three Common
Microdialysis Membranes. J. Neurochem. 1992, 59 (5), 1778−1785.
(8) Berridge, K. C.; Robinson, T. E.; Aldridge, J. W. Dissecting
Components of Reward: ‘Liking’, ‘Wanting’, and Learning. Curr. Opin.
Pharmacol. 2009, 9 (1), 65−73.
(9) The Dopamine Receptors, 2nd ed.; Neve, K., Ed.; Humana Press:
Portland, 2010.
(10) Stoker, T. B.; Torsney, K. M.; Barker, R. A. Emerging
Treatment Approaches for Parkinson’s Disease. Front. Neurosci. 2018,
DOI: 10.3389/fnins.2018.00693.
(11) Simpkins, J. W.; Bodor, N. The Brain-Targeted Delivery of
Dopamine Using a Redox-Based Chemical Delivery System. Adv.
Drug Delivery Rev. 1994, 14 (2), 243−249.
(12) Hargraves, R.; Freed, W. J. Chronic Intrastriatal Dopamine
Infusions in Rats with Unilateral Lesions of the Substantia Nigra. Life
Sci. 1987, 40 (10), 959−966.
(13) Laloux, C.; Gouel, F.; Lachaud, C.; Timmerman, K.; Do Van,
B.; Jonneaux, A.; Petrault, M.; Garcon, G.; Rouaix, N.; Moreau, C.;
et al. Continuous Cerebroventricular Administration of Dopamine: A
New Treatment for Severe Dyskinesia in Parkinson’s Disease?
Neurobiol. Dis. 2017, 103, 24−31.
(14) Cavallo, A.; Madaghiele, M.; Masullo, U.; Lionetto, M. G.;
Sannino, A. Photo-Crosslinked Poly(Ethylene Glycol) Diacrylate
(PEGDA) Hydrogels from Low Molecular Weight Prepolymer:
Swelling and Permeation Studies. J. Appl. Polym. Sci. 2017, 134 (2),
44380.
(15) Perera, D.; Medini, M.; Seethamraju, D.; Falkowski, R.; White,
K.; Olabisi, R. M. The Effect of Polymer Molecular Weight and Cell
Seeding Density on Viability of Cells Entrapped within PEGDA
Hydrogel Microspheres. J. Microencapsulation 2018, 35 (5), 475−481.
(16) Piel, M.; Thery, M. Micropatterning in Cell Biology, 1st ed.;
Academic Press: San Diego, 2014; Vol. 119.
(17) Yao, H.; Wang, J.; Mi, S. Photo Processing for Biomedical
Hydrogels Design and Functionality: A Review. Polymers (Basel,
Switz.) 2018, 10 (1), 11.
(18) Wu, P.-J.; Lilly, J. L.; Arreaza, R.; Berron, B. J. Hydrogel Patches
on Live Cells through Surface Mediated Polymerization. Langmuir
2017, 33 (27), 6778−6784.
(19) Chan, V.; Zorlutuna, P.; Jeong, J. H.; Kong, H.; Bashir, R.
Three-Dimensional Photopatterning of Hydrogels Using Stereo-
lithography for Long-Term Cell Encapsulation. Lab Chip 2010, 10
(16), 2062−2070.
(20) Proctor, C. M.; Sleźia, A.; Kaszas, A.; Ghestem, A.; del Agua, I.;
Pappa, A.-M.; Bernard, C.; Williamson, A.; Malliaras, G. G.
Electrophoretic Drug Delivery for Seizure Control. Science Advances
2018, 4 (8), eaau1291.
(21) Tudor, A.; Delaney, C.; Zhang, H.; Thompson, A. J.; Curto, V.
F.; Yang, G.-Z.; Higgins, M. J.; Diamond, D.; Florea, L. Fabrication of
Soft, Stimulus-Responsive Structures with Sub-Micron Resolution via
Two-Photon Polymerization of Poly(Ionic Liquid)s. Mater. Today
2018, 21 (8), 807−816.
(22) Tanaka, Y. Ion Exchange Membranes: Fundamentals and
Applications; Elsevier: Amsterdam, 2007.
(23) Gualandi, I.; Tonelli, D.; Mariani, F.; Scavetta, E.; Marzocchi,
M.; Fraboni, B. Selective Detection of Dopamine with an All
PEDOT:PSS Organic Electrochemical Transistor. Sci. Rep. 2016, 6,
35419.
(24) Ensafi, A. A.; Taei, M.; Khayamian, T. A Differential Pulse
Voltammetric Method for Simultaneous Determination of Ascorbic
Acid, Dopamine, and Uric Acid Using Poly (3-(5-Chloro-2-
Hydroxyphenylazo)-4,5-Dihydroxynaphthalene-2,7-Disulfonic Acid)
Film Modified Glassy Carbon Electrode. J. Electroanal. Chem. 2009,
633 (1), 212−220.
(25) Uguz, I.; Proctor, C. M.; Curto, V. F.; Pappa, A.-M.; Donahue,
M. J.; Ferro, M.; Owens, R. M.; Khodagholy, D.; Inal, S.; Malliaras, G.
G. A Microfluidic Ion Pump for In Vivo Drug Delivery. Adv. Mater.
2017, 29 (27), 1701217.
(26) Proctor, C. M.; Uguz, I.; Slezia, A.; Curto, V.; Inal, S.;
Williamson, A.; Malliaras, G. G. An Electrocorticography Device with
an Integrated Microfluidic Ion Pump for Simultaneous Neural
Recording and Electrophoretic Drug Delivery In Vivo. Advanced
Biosystems 2019, 3 (2), 1800270.
(27) Åkerman, S.; Viinikka, P.; Svarfvar, B.; Jar̈vinen, K.; Kontturi,
K.; Nas̈man, J.; Urtti, A.; Paronen, P. Transport of Drugs across
Porous Ion Exchange Membranes. J. Controlled Release 1998, 50 (1),
153−166.
Chemistry of Materials Article
DOI: 10.1021/acs.chemmater.9b02135
Chem. Mater. 2019, 31, 7080−7084
7084
